Prime Capital Investment Advisors’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-10,657
Closed -$26.3K – 1047
2025
Q4
$26.3K Buy
10,657
+561
+6% +$1.34K ﹤0.01% 1011
2025
Q3
$22.5K Sell
10,096
-1,753
-15% -$4.01K ﹤0.01% 993
2025
Q2
$28.6K Sell
11,849
-128
-1% -$312 ﹤0.01% 939
2025
Q1
$27.9K Sell
11,977
-5,183
-30% -$10.4K ﹤0.01% 1039
2024
Q4
$31.7K Sell
17,160
-525
-3% -$1.16K ﹤0.01% 921
2024
Q3
$43.2K Buy
17,685
+4,861
+38% +$10.9K ﹤0.01% 904
2024
Q2
$26.3K Sell
12,824
-2,303
-15% -$5.25K ﹤0.01% 911
2024
Q1
$37.5K Buy
+15,127
New +$39.4K ﹤0.01% 986

Other funds holding ABEV

Prime Capital Investment Advisors's ABEV Position: Q1 2026 in Review

Prime Capital Investment Advisors sold out of Ambev (ABEV) in Q1 2026, closing a stake of 10,657 shares — an estimated $26.3K sold.

Prime Capital Investment Advisors first reported a position in ABEV in Q1 2024 and held it in 8 quarters. The position peaked at $43.2K in Q3 2024. 404 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Prime Capital Investment Advisors reported no remaining Ambev position as of Q1 2026 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 10,657 Ambev shares in Q1 2026, an estimated $26.3K.
  • Prime Capital Investment Advisors first reported a position in Ambev in Q1 2024 and held it in 8 quarters.
  • Prime Capital Investment Advisors's Ambev position peaked at $43.2K in Q3 2024.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.